CRYSTALLINE FORM OF (3R,5R)-7-[4-BENZYLCARBAMOYL-2-(4-FLUOROPHENYL)-5-ISOPROPYL-IMIDAZOL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID SODIUM SALT

PROBLEM TO BE SOLVED: To provide a new crystalline form of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt. SOLUTION: This new crystalline form A of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihyd...

Full description

Saved in:
Bibliographic Details
Main Author MILLER JONATHAN MARK
Format Patent
LanguageEnglish
Published 17.05.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract PROBLEM TO BE SOLVED: To provide a new crystalline form of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt. SOLUTION: This new crystalline form A of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt is described. COPYRIGHT: (C)2007,JPO&INPIT
AbstractList PROBLEM TO BE SOLVED: To provide a new crystalline form of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt. SOLUTION: This new crystalline form A of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt is described. COPYRIGHT: (C)2007,JPO&INPIT
Author MILLER JONATHAN MARK
Author_xml – fullname: MILLER JONATHAN MARK
BookMark eNqNiksKwjAUALvQhb87BFct-MD-KC5jktLIa19JKxhFikhcSSvoGTy3LjyAq2GYmXqjfujdxHsLY5uWI-pKsZxMyShnfmxWqQkgg1MCW1UdLQputrwkixCBn0COezJUF6qyGEAKuqH669-sSy35kRBCsHiGeJWC1IWVhg62UHXLK9KCcaEla0jqfckaju3cG98u96db_DjzlrlqRQHuMXTu-bhcXe9e3a6O1ussDDdJFvP4r-kDdkw_dQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID JP2007119473A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2007119473A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:04:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2007119473A3
Notes Application Number: JP20060291882
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070517&DB=EPODOC&CC=JP&NR=2007119473A
ParticipantIDs epo_espacenet_JP2007119473A
PublicationCentury 2000
PublicationDate 20070517
PublicationDateYYYYMMDD 2007-05-17
PublicationDate_xml – month: 05
  year: 2007
  text: 20070517
  day: 17
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies PFIZER PROD INC
RelatedCompanies_xml – name: PFIZER PROD INC
Score 2.6708217
Snippet PROBLEM TO BE SOLVED: To provide a new crystalline form of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CRYSTALLINE FORM OF (3R,5R)-7-[4-BENZYLCARBAMOYL-2-(4-FLUOROPHENYL)-5-ISOPROPYL-IMIDAZOL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID SODIUM SALT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070517&DB=EPODOC&locale=&CC=JP&NR=2007119473A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5zivqmU1GnUkTGBgbXpl3nw5AuaWlH15S2k3UiY-sPEKEbruJ_4N_trW66p70lOTi4hLsv3yW5IHQnJSKsZTrBUVuVsBxLIgYYaeIY4DaVpEeRRMVtC6dlDuTeUBmW0Pv6LUxRJ_SrKI4IHhWBv-dFvJ7_J7FYcbdy8TB9g6HZkxF0WG3NjtVlyaka63Z0lzNOa5R2em7N8QqZCIRdJdoO2oV9tLp0B_25u3yWMt_EFOMI7bmgLsuPUSnJKuiArr9eq6D9_urEG5or51ucoG_qhX6gAft2dAHIW1_ghlAn3r3iNbCKX2Tc1Z1RaFPN62p9HtpYwnUZG_aAe9w1dSe0G1jBls9d6IMY4hbTRtwGfhfar5jcK5hZZsg8PgxN3Q00h1tU0KjFBJ8za9AXfM0OTtGtoQfUxGDQ-G_6xj13w3hyhsrZLEvOkQBcQpqQSJYAn-RWM2rHMKC205SkRI5J-wJVtyi63CqtosPfJKiCRfUKlfOPz-Qa0Duf3hSz_gMiGZFm
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEG4QjfimqFHxx2IMgYRGtm5sPhCztVs23NZlDMMwhsBgiTEBIhj_A_9ujwnKE29tL2ly11y_ftfrFaE7aSzCWqYDnGiqhOWRJGKAkToeAdymkvQgkiTLtvAbdkdudZVuDr2v38JkdUK_suKI4FEJ-Psi269n_0EsluVWzu-HbzA0fbSiJiuv2bG6LDlVZkbTDDjjtExpsxWU_TCTiUDYVaLvoF04Y2vL7w7MZ2P5LGW2iSnWIdoLYLrJ4gjlxpMiKtD112tFtO-tbryhuXK--TH6pmHcjnRg374pAHnzBG4JFRLWlLCKVfwiY8P0e7FL9dDQPR67WMIVGVtuh4c8sE0_dqtYwU6bB9AHMexbTO9xF_hd7L5iUlMwc-yYhbwb22YQ6T53qKBThwltzpyOJ7R1NzpBt5YZURuDQv0_8_VbwYby5BTlJ9PJ-AwJwCWkAUlkCfBJbtQTbQQDqpamJCXyiGjnqLRloout0htUsCPP7YNFnkro4DcgqmBRvUT5xcfn-AqQfDG8zlbgBx0clFY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+FORM+OF+%283R%2C5R%29-7-%5B4-BENZYLCARBAMOYL-2-%284-FLUOROPHENYL%29-5-ISOPROPYL-IMIDAZOL-1-YL%5D-3%2C5-DIHYDROXYHEPTANOIC+ACID+SODIUM+SALT&rft.inventor=MILLER+JONATHAN+MARK&rft.date=2007-05-17&rft.externalDBID=A&rft.externalDocID=JP2007119473A